loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for r1_cep_1996_031___rev_02 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    Jenapharm GmbH & Co KG DE 07745 Jena

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Jenapharm GmbH & Co KG Jena DE (1)

    filter

    01 Levonorgestrel (1)

    filter

    01 Germany (1)

    filter

    01 Withdrawn by EDQM Failure to CEP procedure (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    Jenapharm GmbH & Co KG Jena DE

    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag Germany
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      Levonorgestrel

      PDF Supplier PDF
      URL Supplier Web Content
      R1-CEP 1996-031 - Rev 02
      Withdrawn by EDQM F...
      Chemical
      2006-12-03
      2008-04-11
      926
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content

      Looking for Certificates of Suitability (CEPs) for R1-CEP 1996-031 - Rev 02 of Jenapharm Gmbh & Co Kg Jena De

      Looking for Certificates of Suitability (CEPs) for R1-CEP 1996-031 - Rev 02 of Jenapharm Gmbh & Co Kg Jena De 1

      20

      Jenapharm Gmbh & Co Kg Jena De, based in Germany, is a pharmaceutical company.

      One of their significant offerings is Levonorgestrel, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R1-CEP 1996-031 - Rev 02

      This Chemical Type CEP, issued on December 03, 2006, remains in force until April 11, 2008, ensuring its reliability within the pharmaceutical industry.

      Substance Number 926 associated with this CEP further emphasizes

      Post Enquiry
      POST ENQUIRY